Breast
Health officials say now’s the time to catch up on breast cancer screening
TOPEKA, Kan. (WIBW) – Even before COVID, some women avoided breast cancer screenings because they feared the process. The pandemic seemed to bring another reason to put off the exams. The American College of Radiology notes a 37 percent decline in screening mammograms during the COVID pandemic. A recent study from the group found the …
Breast Cancer Awareness | Georgia Department of Public Health
BCAM_Banner 1.jpg Take Charge of Your Health, Get Screened! Knowing Your Family History Could Help Save Your Life Did you know that 10% of cancer is hereditary? Your family history and genetics are tools for cancer prevention The Georgia Department of Public Health has partnered with Georgia CORE to offer genetic testing of 35 genes …
Survivor Credits Cutting Edge Technology For Best Chance In Fight Against Aggressive Breast Cancer
According to statistics, about 1 in every 8 U.S. women will get a breast cancer diagnosis during their lifetime. As technology improves people can catch their cancer earlier than before. Lorie Wade took advantage of those medical advancements. Wade survived an aggressive breast cancer diagnosis back in 2017. She said she owes her life to the …
Datopotamab Deruxtecan Late-Breaking Data at ESMO Breast Shows Promising Preliminary Response and Disease Control in Patients with Metastatic Triple Negative Breast Cancer
TOKYO & MUNICH & BASKING RIDGE, N.J.–(BUSINESS WIRE)–New data from Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and AstraZeneca’s datopotamab deruxtecan (Dato-DXd), a TROP2 directed DXd antibody drug conjugate (ADC), showed preliminary response and disease control in patients with metastatic triple negative breast cancer (TNBC) with disease progression following standard treatment. These preliminary data from …
GenesisCare and PreludeDx™ Partner to Provide Access to Ground-Breaking Precision Medicine Test for Women With Early-Stage Breast Cancer
SYDNEY & LAGUNA HILLS, Calif.–(BUSINESS WIRE)–GenesisCare, a leading provider of integrated cancer care globally, and Prelude Corporation (PreludeDxTM), a leader in molecular diagnostics and precision medicine, today announced a new strategic partnership aimed at increasing access to personalized breast cancer treatment and improved patient outcomes. DCISionRT® is a precision medicine test for women diagnosed with …
Breast Lesion Localization Methods Market Growing Technology Trends Led by SOMATEX Medical Technologies, CP Medical, Cianna Medical, Tsunami – KSU
Breast Lesion Localization Methods Market research report delivers a comprehensive study on production capacity, consumption, import and export for all major regions across the world. Report provides is a professional inclusive study on the current state for the market. Analysis and discussion of important industry like market trends, size, share, growth estimates are mentioned in …
Breast care takes the stage at new Women’s Center | LMH Health
Jessica Brewer, LMH Health The new Women’s Center at LMH West was designed with convenience, time and care for our patients in mind. One major goal was to provide a center for our patients that could handle most of the care they needed all under one roof, just a seconds walk away from each other. …
Tower Health emphasizes importantance of annual mammograms during Breast Cancer Awareness Month and coronavirus pandemic | Health
An estimated 12,180 women in Pennsylvania will be diagnosed with breast cancer this year. According to the American Cancer Society, one in eight women will be diagnosed with invasive breast cancer in their lifetime, and one in 39 will die from breast cancer. In Pennsylvania, one in seven women will be diagnosed with breast cancer. …
iCAD Hosting Technology Innovation Webinar on the Evolving Landscape for Treating Patients with Brain, Breast, and Rectal CancersWebinar Taking Place on Wednesday, October 21st @ 10amET
NASHUA, N.H., Oct. 16, 2020 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will host a technology innovation webinar on the current treatment landscape and unmet medical needs for treating cancer, on Wednesday, October 21, 2020, at 10am Eastern Time. …
iCAD Hosting Technology Innovation Webinar on the Evolving Landscape for Treating Patients with Brain, Breast, and Rectal Cancers Nasdaq:ICAD
NASHUA, N.H., Oct. 16, 2020 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will host a technology innovation webinar on the current treatment landscape and unmet medical needs for treating cancer, on Wednesday, October 21, 2020, at 10am Eastern Time. …
